Big data study aims to speed up breast cancer treatment insights
NCT ID NCT03676257
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study looked at records from over 20,000 women with metastatic breast cancer in France. Researchers wanted to see if earlier measures of treatment success, like progression-free survival, could reliably predict overall survival. By comparing real-world data to clinical trial results, they hope to find faster ways to evaluate new treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could help doctors use real-world data to predict treatment benefits earlier, potentially speeding up access to effective therapies.
- What could go wrong
- This is an observational study using existing records, not a controlled trial. The findings may not apply to all patients or treatments, and real-world data can be incomplete or biased.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Insitut Bergonié
Bordeaux, 33076, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Drug attack shrink Hard-to-Treat breast cancer?
- Can mapping tumor DNA unlock personalized breast cancer care?
- Could a personal coach at home boost energy for cancer patients?
- Can an immune booster help chemotherapy fight metastatic breast cancer?
- Can a Four-Drug cocktail tame a tough breast cancer?
- Can a new drug outsmart resistant breast cancer?